Improving outcome after stroke: Time to treat new targets

Stroke

Volumn 43, Issue 2, 2012, Pages 295-296

  Minnerup, Jens ^a   Schäbitz, Wolf Rüdiger ^b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

complications; prophylactic treatment; stroke

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CEFTRIAXONE; FLUOXETINE; HLA DR ANTIGEN; MEZLOCILLIN; MOXIFLOXACIN; PLACEBO; SULBACTAM;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTIHYPERTENSIVE THERAPY; BRAIN BLOOD VESSEL; BRAIN INFARCTION; CENTRAL SLEEP APNEA SYNDROME; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DETERIORATION; DISEASE ASSOCIATION; DYSPHAGIA; EDITORIAL; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; HYPERCAPNIA; HYPERTENSION; INFECTION COMPLICATION; INFECTION RISK; MORTALITY; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PATIENT CARE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RISK REDUCTION; SECONDARY PREVENTION; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; STROKE;

COGNITION DISORDERS; DEPRESSIVE DISORDER; HUMANS; QUALITY IMPROVEMENT; SLEEP APNEA, OBSTRUCTIVE; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84856433185     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.642363     Document Type: Editorial

References (22)

1. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25:457-507.
2. Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE, Adams RJ, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke. 1998;29: 447-453. (Pubitemid 28086690)
3. Bassetti C, Aldrich MS, Quint D. Sleep-disordered breathing in patients with acute supra-and infratentorial strokes. A prospective study of 39 patients. Stroke. 1997;28:1765-1772. (Pubitemid 27391447)
4. Balami JS, Chen RL, Grunwald IQ, Buchan AM. Neurological complications of acute ischaemic stroke. Lancet Neurol. 2011;10:357-371.
5. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev. 2008;4:CD003437.
6. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: A randomized controlled trial. JAMA. 2008;299:2391-2400. (Pubitemid 351749237)
7. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): A randomised placebo-controlled trial. Lancet Neurol. 2011;10:123-130.
8. Minnerup J, Wersching H, Brokinkel B, Dziewas R, Heuschmann PU, Nabavi DG, et al. The impact of lesion location and lesion size on poststroke infection frequency. J Neurol Neurosurg Psychiatry. 2010;81: 198-202.
9. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis. 2006;15:209-213. (Pubitemid 44332971)
10. Schwarz S, Al Shajlawi F, Sick C, Meairs S, Hennerici MG. Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS). Stroke. 2008;39:1220-1227. (Pubitemid 351440694)
11. Harms H, Prass K, Meisel C, Klehmet J, Rogge W, Drenckhahn C, et al. Preventive antibacterial therapy in acute ischemic stroke: A randomized controlled trial. PLoS One. 2008;3:e2158.
12. Nederkoorn PJ, Westendorp WF, Hooijenga IJ, de Haan RJ, Dippel DW, Vermeij FH, et al. Preventive antibiotics in stroke study: rationale and protocol for a randomised trial. Int J Stroke. 2011;6:159-163.
13. Hilker R, Poetter C, Findeisen N, Sobesky J, Jacobs A, Neveling M, et al. Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke. 2003;34:975-981. (Pubitemid 36402972)
14. Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: A meta-analysis. J Clin Sleep Med. 2010;6:131-137.
15. Alexandrov AV, Nguyen HT, Rubiera M, Alexandrov AW, Zhao L, Heliopoulos I, et al. Prevalence and risk factors associated with reversed Robin Hood syndrome in acute ischemic stroke. Stroke. 2009;40: 2738-2742.
16. Ryan CM, Bayley M, Green R, Murray BJ, Bradley TD. Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke. 2011;42:1062-1067.
17. Martinez-Garcia MA, Soler-Cataluna JJ, Ejarque-Martinez L, Soriano Y, Roman-Sanchez P, Illa FB, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: A 5-year follow-up study. Am J Respir Crit Care Med. 2009;180:36-41.
18. Dziewas R, Humpert M, Hopmann B, Kloska SP, Ludemann P, Ritter M, et al. Increased prevalence of sleep apnea in patients with recurring ischemic stroke compared with first stroke victims. J Neurol. 2005;252: 1394-1398. (Pubitemid 41699032)
19. Bassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke. 2006;37:967-972.
20. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: A systematic review and meta-analysis. Lancet Neurol. 2009;8:1006-1018.
21. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069-1075. (Pubitemid 36548935)
22. Alvarez-Sabin J, Roman GC. Citicoline in vascular cognitive impairment and vascular dementia after stroke. Stroke. 2011;42:S40-S43.